Transglutaminases: Crosslinking enzymes with pleiotropic functions

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 2, 2003, Pages 140-156

  Lorand, Laszlo ^a   Graham, Robert M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AUTOIMMUNE DISEASE; BLOOD CLOTTING; CATALYSIS; COVALENT BOND; CROSS LINKING; CYTOSKELETON; DEGENERATIVE DISEASE; EXTRACELLULAR MATRIX; FERTILIZATION; GENETIC DISORDER; HUMAN; INFLAMMATION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RIGIDITY; SKIN FUNCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CROSS-LINKING REAGENTS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; TRANSGLUTAMINASES;

EID: 0037317032     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1014     Document Type: Review

References (150)

1. Sarkar, N. K., Clarke, D. D. & Waelsch, H. An enzymically catalyzed incorporation of amines into proteins. Biochim. Biophys. Acta 25, 451-452 (1957). This is the first report of the discovery of a transglutaminase.
2. Cariello, L., et al. Probing the transglutaminase-mediated, posttranslational modification of proteins during development. Biochemistry 29, 5103-5108 (1990).
3. Nemes, Z., Marekov, L. N., Fesus, L. & Steinert, P. M. A novel function for transglutaminase 1: attachment of long-chain ω-hydroxyceramides to involucrin by ester bond formation. Proc. Natl. Acad. Sci. USA 96, 8402-8407 (1999). This article reports the identification of the previously unrecognised potential of TGs to catalyse posttranslational protein modification by linking longchain fatty acids (ceramides) through an ester bond (see reaction d in FIG. 1).
4. Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2218-2220 (2002). This article shows that in vitro treatment of prolinerich deamidated pepticies with the enzyme prolylendopeptidase destroys their antigenic properties, offering perhaps a strategy for oral peptidase supplement therapy in lieu of a gluten-free diet in gluten sensitivity diseases.
5. Lorand, L., Campbell, L. & Robertson, B. in Biochemistry Vol. 11 (ed. Green, D) 434-438 (CRC Press, Boca Raton, USA, 1972).
6. Lorand, L. Acquired inhibitors of fibrin stabilization: a class of hemorrhagic disorders of diverse origins Anticoagulants, Physiologic, Pathologic and Pharmacologic, 169-191 (1994)
7. Galli, F., et al. Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis. Kidney Int. Suppl. 78, S73-76 (2001).
8. Kang, H., Lee, S. G. & Cho, Y. D. Identification of glycinin in vivo as a poiyamine-conjugated protein via a γ-glutamyl linkage. Biochem. J. 332, 467-473 (1998).
9. Curtis, C. G., et al. Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase. Biochemistry 13, 3257-3262 (1974). The unique specificity for amine substrates, as described in this article, is a characteristic feature of TGs that sets them apart from the evolutionarily related papain family of enzymes.
10. Williams-Ashman, H, G., Notides, A. C., Pabalan, S. S. & Lorand, L. Transamidase reactions involved in the enzymic coagulation of semen: isolation of γ-glutamyl-ε-lysine dipeptide from clotted secretion protein of guinea pig seminal vesicle. Proc. Natl Acad. Sci. USA 69, 2322-2325 (1972)
11. Lorand, L., Doolittle, R. F., Konishi, K. & Riggs, S. K. A new class of blood coagulation inhibitors. Arch. Biochem. Biophys 102, 171-179 (1963).
12. Williams-Ashman, H, G., Wilson, J., Beil, R. & Lorand, L. Transglutaminase reactions associated with the rat semen clotting system: modulation by macromolecular polyanions. Biochem. Biophys. Res. Commun. 79, 1192-1198 (1977).
13. Bruner-Lorand, J., Urayama, T. & Lorand, L. Transglutaminase as a blood clotting enzyme. Biochem. Biophys. Res. Commun. 23, 828-834 (1966).
14. Brozen, R., et al. The antiquity of transglutaminase: an intracellular enzyme from marine sponge cells enhances clotting of lobster plasma. Biol Bull. 173, 423 (1987).
15. Lorand, L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann. N. Y. Acad. Sci. 936, 291-311 (2001). A recent review on coagulation factor XIII (fXIII).
16. Battaglia, D. E. & Shapiro, B. M. Hierarchies of protein cross-linking in the extracellular matrix: involvement of an egg surface transglutaminase in early stages of fertilization envelope assembly. J. Cell Biol. 107, 2447-2454 (1988).
17. Ha, C. R. & luchi, I. Enzyme responsible for egg envelope (chorion) hardening in fish: purification and partial characterization of two transglutaminases associated with their substrate, unfertilized egg chorion, of the rainbow trout, Oncorhynchus mykiss. J. Biochem. 124, 917-926 (1998).
18. Eitan, S., et al. Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science 264, 1764-1768 (1994).
19. Sundstrom, P., Balish, E. & Allen, C. M. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J. Infect. Dis. 185, 521-530 (2002).
20. Sugino, H., et al. Molecular characterization of a novel nuclear transglutaminase that is expressed during starfish embryogenesis. Eur. J. Biochem. 269, 1957-1967 (2002).
21. Saber-Lichtenberg, Y., et al. Covalent cross-linking of secreted bovine thyroglobulin by transglutaminase. FASEB J. 14, 1005-1014 (2000).
22. Walker, A. M., et al. Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes, Proc. Natl. Acad. Sci. USA 92, 3278-3282 (1995)
23. Lu, W., Strohecker, A. & Ou Jh, J. H. Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase. J. Biol. Chem. 276, 47993-47999 (2001).
24. Chen, J. S. & Mehta, K. Tissue transglutaminase: an enzyme with a split personality. Int. J. Biochem. Cell Biol. 31, 817-836 (1999).
25. Makarova, K., Aravind, L. & Koonin, E. A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases. Protein Sci. 8, 1714-1719 (1999).
26. Kanaji, T., et al. Primary structure of microbial transglutaminase from Streptoverticillium sp. strain s-8112. J. Biol. Chem. 268, 11565-11572 (1993).
27. Kashiwagi, T., et al. Crystal structure of microbial transglutaminase from Streptoverticillium mobaraense. J. Biol. Chem. 277, 44252-44260 (2002). This is the first report of the high-resolution structure of a bacterial TG, which shows that its common catalytic mechanism, with that of the papain-like TGs, has resulted from convergent evolution.
28. Murzin, A. G., Brenner, S. E., Hubbard, T. & Chothia, C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247, 536-540 (1995).
29. Sinclair, J. C., et al. Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nature Struct. Biol. 7, 560-564 (2000).
30. Rodrigues-Lima, F., et al. Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. Biochem. J. 356, 327-334 (2001).
31. Yee, V. C., et al. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII, Proc. Natl. Acad. Sci. USA 91, 7296-7300 (1994). This landmark paper presents the first high-resolution structure of any member of the TG family and, importantly, clearly defines these enzymes as members of the superfamily of papain-like cysteine proteases.
32. Noguchi, K., et al. Crystal structure of red sea bream transglutaminase, J. Biol. Chem. 276, 12055-12059 (2001).
33. Liu, S., Cerione, R. A. & Clardy, J. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc. Natl. Acad. Sci. USA 99, 2743-2747 (2002). This article reports the first high-resolution structure of human TG2 and the identification of its residues that potentially form a unique guanine-nucleotide binding-pocket.
34. Ahvazi, B., et al. Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation EMBO J. 21, 2055-2067 (2002). This article reports the first high-resolution structure of an activated form of a TG. It also provides further structural evidence to support a concept proposed by Jabs et al. in reference 59, that cis-trans isomerization of non-proline peptide bonds is crucial to the activation process of TGs.
35. Grenard, P., Bates, M. K. & Aeschlimann, D. Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J. Biol. Chem. 276, 33066-33078 (2001). This important paper reports the first identification of the genes and genomic organization of two novel members of the mammalian TG family, TG5 and TG7.
36. Shevchenko, Y. O., et al, Splice-site mutation in TGM1 in congenital recessive ichthyosis in Amercan families: molecular, genetic, genealogic, and clinical studies. Hum. Genet. 106, 492-499 (2000).
37. Kim, I. G., et al. Structure and organization of the human transglutaminase 1 gene. J. Biol. Chem. 267, 7710-7717 (1992).
38. Citron, B. A., SantaCruz, K. S., Davies, P. J. & Festoff, B. W. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J. Biol. Chem. 276, 3295-3301 (2001).
39. Bouhassira, E. E., et al. An alanine-to-threonine substitution in protein 4.2 cDNA is associated with a Japanese form of hereditary hemolytic anemia (protein 4 2NIPPON). Blood 79, 1846-1854 (1992).
40. Polakowska, R. R., et al. Organization and evolution of the human epidermal keratinocyte transglutaminase I gene. Proc. Natl. Acad. Sci. USA 89, 4476-4480 (1992).
41. Tokunaga, F., et al. Limulus hemocyte transglutaminase. cDNA cloning, amino acid sequence, and tissue localization. J. Biol. Chem. 268, 262-268 (1993).
42. Jessen, B. A., Qin, Q. & Rice, R. H. Functional AP1 and CRE response elements in the human keratinocyte transglutaminase promoter mediating Whn suppression. Gene 254, 77-85 (2000).
43. Kida, M., et al. Transcriptional regulation of cell type-specific expression of the TATA-less A subunit gene for human coagulation factor XIII. J. Biol. Chem. 274, 6138-6147 (1999).
44. Medvedev, A., et al. Regulation of the transglutaminase I gene, Identification of DNA elements involved in its transcriptional control in tracheobronchial epithelial cells. J. Biol. Chem. 274. 3887-3896 (1999).
45. Polakowska, R. R., Graf, B. A., Falciano, V. & LaCelle, P. Transcription regulatory elements of the first intron control human transglutaminase type I gene expression in epidermal keratinocytes. J. Cell Biochem. 73, 355-369 (1999).
46. Dubbink, H. J., et al. An Sp1 binding site is essential for basal activity of the human prostate-specific transglutaminase gene (TGM4) promoten. Gene 240, 261-267 (1999).
47. Ritter, S. J. & Davies, P. J. Identification of a transforming growth factor-β1/bone morphogenetic protein 4 (TGFβ1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 273, 12798-12806 (1998).
48. Dubbink, H. J., et al. The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization. Genomics 51, 434-444 (1998).
49. Lee, J. H., et al. The proximal promoter of the human transglutaminase 3 gene. Stratified squamous epithelial- specific expression in cultured cells is mediated by binding of Sp1 and ets transcription factors to a proximal promoter element. J. Biol. Chem. 271, 4561-4568 (1996).
50. Km, I. G., et al. Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family. J. Invest. Dermatol. 103, 137-142 (1994).
51. Korsgren, C. & Cohen, C. M. Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII. Proc. Natl. Acad. Sci. USA 68, 4840-4844 (1991).
52. Aeschlimann, D, & Thomazy, V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect. Tissue Res. 41, 1-27 (2000).
53. Lorand, L., et al. Isolation of transglutaminase-reactive sequences from complex biological systems: a prominent lysine donor sequence in bovine lens. Proc. Natl. Acad. Sci Natl Acad. Sci. USA 89, 11161-11163 (1992).
54. Murthy, S, N., Wilson, J., Zhang, Y. & Lorand, L. Residue Gin-30 of human erythrocyte anion transporter is a prime site for reaction with intrinsic transglutaminase. J. Biol. Chem. 269, 22907-22911 (1994).
55. Fesus, L. & Laki, K. Two antigenic sites of tissue transglutaminase. Biochemistry 16, 4061-4066 (1977).
56. Lorand, L., et al Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner. Blood 93, 909-917 (1999).
57. Fox, B. A., et al. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by x-ray crystallography. J. Biol. Chem. 274, 4917-4923 (1999).
58. Curtis, C. G., et al. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry 13, 3774-3780 (1974).
59. Jabs, A., Weiss, M. S. & Hilgenfeld, R. Non-proline cis peptide bonds in proteins. J. Mol. Biol. 286, 291-304 (1999).
60. Cariello, L., Wilson, J. & Lorand, L. Activation of transglutaminase during embryonic development. Biochemistry 23, 6843-6850 (1984).
61. Dadabay, C. Y. & Pike, L. J. Rapid increases in the transglutaminase activity of A431 cells following treatment with epidermal growth factor. Biochemistry 26, 6587-6591 (1987).
62. 2+-enriched human erythrocytes and activated platelets. Biochemistry 26, 308-313 (1987).
63. Bergamini, C. M., Signorini, M. & Poltronieri, L. Inhibition of erythrocyte transglutaminase by GTP. Biochim. Biophys. Acta. 916, 149-151 (1987).
64. Lorand, L., Siefring, G. E. J. & Lowe-Krentz, L. in Membrane Transport in Erythrocytes Vol. 14 (eds U. V. Lassen. H. J. H. Ussing & J. O. Wieth) 285-299 (Munksgaard, Copenhagen, 1980).
65. Lorand, L., et al. Cross-linked polymers in the red cell membranes of a patient with Hb-Koln disease. Biochem. Biophys. Res. Commun. 147, 602-607 (1987).
66. Muszbek, L., et al. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity. Thromb. Haemost. 59, 231-235 (1988).
67. Szasz, R. & Dale, G. L. Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood 100, 2827-2831 (2002).
68. Steinert, P. M. & Marekov, L. N. Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia Mol. Biol. Cell 10, 4247-4261 (1999).
69. Kalinin, A., Marekov, L. N. & Steinert, P. M. Assembly of the epidermal cornified cell envelope. J. Cell Sci. 114, 3069-3070 (2001).
70. Kim, H. C., et al. Crystallization and preliminary X-ray analysis of human transglutaminase 3 from zymogen to active form. J. Struct. Biol 135, 73-77 (2001).
71. Fesus, L. & Piacentini, M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27, 534-539 (2002).
72. Thomazy, V. & Fesus, L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study Cell. Tissue Res. 255, 215-224. (1989).
73. 2+ and nucleotides. Biochem. J. 313, 803-808 (1996). This paper provides an important evaluation of intracellular TG activity and direct evidence that under physiological conditions the transamidation activity of TG2 is latent.
74. Fesus, L., Thomazy, V. & Falus, A. Induction and activation of tissue transgrutaminase during programmed cell death. FEBS Lett. 224, 104-108 (1987).
75. Melino, G., et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell Biol. 14, 6584-6596 (1994).
76. Nanda, N., et al. Targeted inactivation of Gh/tissue transglutaminase II. J. Biol. Chem 276, 20673-20678 (2001).
77. Lorand, L., Hsu, L. K., Siefring, G. E., Jr. & Rafferty, N. S. Lens transglutaminase and cataract formation. Proc. Natl. Acad. Sci. USA 78, 1356-1360 (1981).
78. Lesort, M., Attanavanich, K., Zhang, J. & Johnson, G. V. Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem 273, 11991-11994 (1998).
79. Peng, X., et al. Interaction of tissue transglutaminase with nuclear transport protein importin-α3. FEBS Lett 446, 35-39 (1999).
80. Achyuthan, K. E. & Greenberg, C. S. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J. Biol. Chem. 262, 1901-1906 (1987).
81. Nakaoka, H., et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264, 1593-1596 (1994). An important paper that provides the first evidence that some TGs (TG2) can act uniquely as multifunctional proteins with reciprocally regulated crosslinking and G-protein signalling actions - their seemingly unique ability to bind and hydrolyse GTP having been identified earlier (reference 80).
82. Baek, K. J., et al. A 50 KDa protein modulates guanine nucleotide binding of transglutaminase II. Biochemistry 35, 2651-2657. (1996).
83. Iismaa, S. E., et al. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J. Biol. Chem. 275, 18259-18265 (2000).
84. Gentile, V., et al. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell Biol. 119, 463-474 (1992).
85. Piacemntini, M., et al. In vivo and in vitro induction of 'tissue' transglutaminase in rat hepatocytes by retinoic acid. Biochim. Biophys. Acta. 1135, 171-179 (1992).
86. Zhang, J., Lesort, M., Guttmann, R. P. & Johnson, G. V. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J. Biol. Chem. 273, 2288-2295 (1998).
87. Verderio, E., Nicholas, B., Gross, S. & Griffin, M. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res. 239, 119-138 (1998).
88. Akimov, S. S., Krylov, D., Fleischman, L. F. & Belkin, A. M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148, 825-838 (2000).The ability of TG2 to function as an extracellular mediator of integrin signalling by a mechanism independent of its crosslinking activity was reported for the first time in this paper.
89. Mian, S., et al. The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett. 370, 27-31 (1995).
90. Gaudry, C. A., et al. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal β-sandwich domain. J. Biol. Chem. 274, 30707-30714 (1999).
91. Akimov, S. S. & Belkin, A. M. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin, Blood 98, 1567-1576 (2001).
92. Aeschlimann, D., Kaupp, O. & Paulsson, M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major grutaminyl substrate. J. Cell. Biol. 129, 881-892 (1995).
93. 3-integrin expression. J. Bone Miner. Res. 15, 1731-1745 (2000).
94. Qian, R. Q. & Glanville, R. W. Alignment of fibrillin molecules in elastic microfibrils is defined by transglutaminase-derived cross-links, Biochemistry 36, 15841-15847 (1997).
95. Aeschlimann, D. & Paulsson, M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J. Biol. Chem 266, 15308-15317 (1991).
96. Raghunath, M., et al. Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase. J. Clin. Invest. 98, 1174-1184 (1996).
97. Trask, B. C., et al. Posttranslational modifications of microfibril associated glycoprotein-1 (MAGP-1), Biochemistry 40, 4372-4380 (2001).
98. Nunes, I., Gleizes, P. E., Metz, C. N. & Rifkin, D. B. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J. Cell Biol. 138, 1151-1163 (1997).
99. Lorand, L., Dailey, J. E. & Turner, P. M. Fibronectin as a carrier for the transglutaminase from human red cells. Proc. Natl. Acad. Sci. 85, 1057-1059 (1988). This is the first report showing that TG2 can form a very tight, non-covalent complex with fibronectin that can further combine with collagen (see also references 100-102). This is essential for cell-matrix interactions and cell migration (reference 91).
100. Turner, P. M. & Lorand, L. Complexation of fibronectin with tissue transglutaminase. Biochemistry 28, 628-635 (1989).
101. Jeong, J. M., Murthy, S. N., Radek, J. T. & Lorand, L. The fibronectin-binding domain of transglutaminase. J. Biol. Chem. 270, 5654-5658 (1995).
102. Radek, J. T., et al. Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc. Natl. Acad. Sci. USA 90, 3152-3156 (1993).
103. Bowness, J., Venditti, M., Tarr, A. & Taylor, J. Increase in epsilon (γ-glutamyl) lysine crosslinks in atherosclerotic aortas. Atherosclerosis 111, 247-53 (1994).
104. Johnson, K., et al. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am. J. Pathol. 159, 149-163 (2001).
105. Kim, S. Y., Jeitner, T. M. & Steinert, P. M. Transglutaminases in disease. Neurochem. Int. 40, 85-103 (2002).
106. Crawford, S. E., et al. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93, 1159-1170 (1998).
107. Mikkola, H., et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 87, 141-181 (1996).
108. Ideguchi, H., Nishimura, J., Nawata, H. & Hamasaki, N. A genetic defect of erythrocyte band 4,2 protein associated with hereditary spherocytosis. Br. J. Haematol. 74, 347-353 (1990).
109. Huber, M., et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267, 525-526 (1995).
110. Names, Z., et al. Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrorysis of glutamine. J. Biol. Chem. 275, 2636-2646 (2000).
111. Sardy, M., et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med. 195, 747-757 (2002).
112. Dieterich, W., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med. 3, 797-801 (1997). An important paper that defines for the first time the involvement of TG2 as an autoantigen in coeliac disease; a finding that led to the development of a now widely used diagnostic test for this disease.
113. Benedetti, L., et al. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87, 1939-1950, (1996).
114. Choi, Y. C., et al. Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2. J. Biol. Chem. 275, 8703-8710 (2000).
115. Esmann, J., Voorhees, J. J. & Fisher, G. J. Increased membrane-associated transglutaminase activity in psoriasis. Biochem. Biophys Res. Commun. 164, 219-224 (1989).
116. Santos, M., et al. Molecular cloning and characterization of a maize transglutaminase complementary DNA. Minerva Biotechnol. 14, 199(abstr.) (2002).
117. Fullner, K. J. & Mekalanos, J. J. In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J. 19, 5315-5323 (2000).
118. Schense, J. C., Bloch, J., Aebischer, P. & Hubbell, J. A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nature Biotechnol. 18, 415-419 (2000).
119. Noll, T., et al. Effect of factor XIII on endothelial barrier function. J. Exp. Med. 189, 1373-1382 (1999).
120. Elbaz, A., et al. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction Blood 95, 586-591 (2000).
121. Bernassola, F., et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J. 16, 1371-1378 (2002).
122. Hitomi, K., Ikura, K. & Maki, M, GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3). Biosci. Biotechnol. Biochem. 64, 657-659 (2000).
123. Lorand, L. Sol Sherry Lecture in Thrombosis: research on clot stabilization provides clues for improving thrombolytic therapies. Arterioscler. Thromb. Vasc. Biol. 20, 2-9 (2000).
124. Chandrashekar, R. & Mehta, K. Transglutaminase-catalyzed reactions in the growth, maturation and development of parasitic nematodes. Parasitol. Today 16, 11-17 (2000).
125. Christie, R. H., et al. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. J. Neurosci. 21, 858-864 (2001).
126. Matsuki, M., et al. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc. Natl Acad. Sci. USA 95, 1044-1049 (1998).
127. De Laurenzi, V. & Melino, G. Gene disruption of tissue transglutaminase. Mol. Cell Biol. 21, 148-155 (2001).
128. Szondy, Z., et al. Tissue transglutaminase is required for phagocytosis of apoptotic cells and to prevent autoimmunity. Minerva Biotechnol. Abstr. 14, 219 (2002).
129. Singer, M. A., Hortsch, M., Goodman, C. S. & Bentley, D. Annulin, a protein expressed at limb segment boundaries in the grasshopper embryo, is homologous to protein cross-linking transglutaminases. Dev. Biol. 154, 143-159 (1992).
130. Wada, F., et al. Identification of mammalian-type transglutaminase in Physarum polycephalum. Evidence from the cDNA sequence and involvement of GTP in the regulation of transamidating activity. Eur. J. Biochem. 269, 3451-3460 (2002).
131. Monczak, Y., Trudel, M., Lamph, W. & Miller, J. W. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR. Blood 90, 3345-3355 (1997).
132. Grabarek, J., Ardelt, B., Kunicki, J. & Darzynkiewicz, Z. Detection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry. Cytometry 49, 83-89 (2002).
133. Nemes, Z. J., et al. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J. Biol. Chem. 272, 20577-20583 (1997).
134. Johnson, T. S., et al. Transglutaminase transcription and antigen translocation in experimental renal scarring. J. Am. Soc. Nephrol. 10, 2146-2157 (1999).
135. Grenard, P., et al. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J. Hepatol. 35, 367-375 (2001).
136. Weinberg, J., Pippen, A. & Greenberg, C. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteroarthritis and rheumatoid arthritis. Arthritis Rheum. 34, 996-1005 (1991).
137. Lesort, M., Tucholski, J., Miller, M. L. & Johnson, G. V. Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog. Neurobiol. 61, 439-463 (2000).
138. Nemes, Z., et al. N(ε)(γ-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol. Aging 22, 403-406 (2001).
139. Jeitner, T. M., et al. N(ε)-(γ-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. J. Neurochem. 79, 1109-1112 (2001).
140. Parameswaran, K. N., et al. Hydrolysis of γ.ε isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J. Biol. Chem. 272, 10311-10317 (1997).
141. Lorand, L. & Conrad, S. M. Transglutaminases. Mol. Cell Biochem. 58, 9-35 (1984).
142. Mosesson, M., Siebenlist, K. & Meh, D. The structure and biological features of fibrinogen and fibrin. Ann. NY Acad. Sci. 936, 11-30 (2001).
143. Feng, J. F., Gray, C. D. & Im, M. J. α1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation. Biochemistry 38, 2224-2232 (1999).
144. Hwang, K. C., Gray, C. D., Sivasubramanian, N. & Im, M. J. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J. Biol. Chem. 270, 27058-27062 (1995).
145. Strimmer, K. & von Haeseler, A. Quartet puzzling: A quartet maximum-likelihood method for reconstructing tree topologies. Mol. Biol. Evol. 13, 964-969 (1996).
146. Jones, D. T., Taylor, W. R. & Thornton, J. M. The rapid generation of mutation data matrices from protein sequences. Comput. Appl. Biosci. 8, 275-282 (1992).
147. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680 (1994).
148. LeMosy, E. K. et al. Visualization of purified fibronectin-transglutaminase complexes. J. Biol. Chem. 267, 7880-7885 (1992)
149. Belkin, A. M. et al. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 276, 18415-18422 (2001).
150. Lorand, L. in Advances in Experimental Medicine and Biology Vol 231 (eds Zappia, V. Galetti, P., Porter, R. & Wold, F.) 79-94 (Kluwer Academic, Plenum, New York, USA, 1988).